blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0941317

EP0941317 - INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R) ANTISENSE OLIGONUCLEOTIDE-TREATED BREAST CANCER CELLS COMPOSITION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.01.2004
Database last updated on 13.09.2024
Most recent event   Tooltip11.12.2009Change - representativepublished on 13.01.2010  [2010/02]
Applicant(s)For all designated states
REGENTS OF THE UNIVERSITY OF MINNESOTA
Morrill Hall, 100 Church Street S.E.
Minneapolis, MN 55455 / US
[N/P]
Former [1999/37]For all designated states
REGENTS OF THE UNIVERSITY OF MINNESOTA
Morrill Hall, 100 Church Street S.E.
Minneapolis MN 55455 / US
Inventor(s)01 / LOW, Walter, C.
19845 Sweetwater Curve
Shorewood, MN 55331 / US
02 / WALLENFRIEDMAN, Margaret, A.
6805 Limerick Lane
Edina, MN 55439 / US
03 / CHIANG, Lan
4230 Underwood Lane North
Plymouth, MN 55442 / US
[1999/37]
Representative(s)Olsen, Lars Pallisgaard, et al
Zacco Denmark A/S
Hans Bekkevolds Allé 7
2900 Hellerup / DK
[N/P]
Former [2010/02]Olsen, Lars Pallisgaard, et al
Zacco Denmark A/S Hans Bekkevolds Allé 7
2900 Hellerup / DK
Former [2003/02]Olsen, Lars Pallisgaard, et al
ZACCO DENMARK A/S Hans Bekkevolds Allé 7
2900 Hellerup / DK
Former [1999/37]Halberg, Kristian, et al
Hofman-Bang & Boutard, Lehmann & Ree A/S, Hans Bekkevolds Allé 7
2900 Hellerup / DK
Application number, filing date97947515.914.11.1997
[1999/37]
WO1997US20815
Priority number, dateUS1996075555822.11.1996         Original published format: US 755558
[1999/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9822579
Date:28.05.1998
Language:EN
[1998/21]
Type: A1 Application with search report 
No.:EP0941317
Date:15.09.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 28.05.1998 takes the place of the publication of the European patent application.
[1999/37]
Type: B1 Patent specification 
No.:EP0941317
Date:12.03.2003
Language:EN
[2003/11]
Search report(s)International search report - published on:EP28.05.1998
ClassificationIPC:C12N15/11, A61K45/00
[2002/13]
CPC:
C12N15/1138 (EP,US); A61P35/00 (EP); A61K38/00 (EP,US)
Former IPC [1999/37]C12N15/11, A61K45/05
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1999/37]
TitleGerman:ZUSAMMENSETZUNG AUS BRUSTKREBSZELLEN, DIE MIT EINEM GEGEN DEN REZEPTOR FÜR INSULIN-ÄHNLICHEN WACHSTUMSFAKTOR GERICHTETEN ANTISENS-OLIGONUKLEOTIDBEHANDELT WORDEN SIND.[1999/37]
English:INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R) ANTISENSE OLIGONUCLEOTIDE-TREATED BREAST CANCER CELLS COMPOSITION[1999/37]
French:COMPOSITION CONSTITUEE DE CELLULES D'UNE TUMEUR CANCEREUSE MAMMAIRE TRAITEES AVEC UN OLIGONUCLEOTIDE ANTISENSE DIRIGE CONTRE LE RECEPTEUR DU FACTEUR DE CROISSANCE IGF DE TYPE 1 (IGF-1R)[2002/13]
Former [1999/37]COMPOSITION DE CELLULES DE CARCINOME MAMMAIRE TRAITEES AVEC UN OLIGONUCLEOTIDE ANTISENS DE RECEPTEUR DE FACTEUR DE CROISSANCE DE TYPE 1 (IGF-1R) TEL QUE L'INSULINE
Entry into regional phase17.06.1999National basic fee paid 
17.06.1999Designation fee(s) paid 
17.06.1999Examination fee paid 
Examination procedure16.06.1998Request for preliminary examination filed
International Preliminary Examining Authority: EP
17.06.1999Examination requested  [1999/37]
15.10.1999Amendment by applicant (claims and/or description)
21.05.2001Despatch of a communication from the examining division (Time limit: M04)
25.09.2001Reply to a communication from the examining division
28.02.2002Despatch of communication of intention to grant (Approval: Yes)
28.05.2002Communication of intention to grant the patent
02.09.2002Fee for grant paid
02.09.2002Fee for publishing/printing paid
Opposition(s)15.12.2003No opposition filed within time limit [2004/10]
Fees paidRenewal fee
21.10.1999Renewal fee patent year 03
20.10.2000Renewal fee patent year 04
22.11.2001Renewal fee patent year 05
25.11.2002Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT12.03.2003
BE12.03.2003
FI12.03.2003
GR12.03.2003
NL12.03.2003
DK12.06.2003
PT12.06.2003
SE12.06.2003
ES30.09.2003
GB14.11.2003
IE14.11.2003
LU14.11.2003
CH30.11.2003
LI30.11.2003
MC30.11.2003
[2005/03]
Former [2005/02]AT12.03.2003
BE12.03.2003
FI12.03.2003
GR12.03.2003
NL12.03.2003
DK12.06.2003
PT12.06.2003
SE12.06.2003
ES30.09.2003
GB14.11.2003
LU14.11.2003
CH30.11.2003
LI30.11.2003
MC30.11.2003
Former [2004/45]AT12.03.2003
BE12.03.2003
FI12.03.2003
GR12.03.2003
NL12.03.2003
DK12.06.2003
PT12.06.2003
SE12.06.2003
ES30.09.2003
GB14.11.2003
LU14.11.2003
CH30.11.2003
LI30.11.2003
Former [2004/44]AT12.03.2003
BE12.03.2003
FI12.03.2003
GR12.03.2003
NL12.03.2003
DK12.06.2003
PT12.06.2003
SE12.06.2003
ES30.09.2003
LU14.11.2003
CH30.11.2003
LI30.11.2003
Former [2004/39]AT12.03.2003
BE12.03.2003
FI12.03.2003
GR12.03.2003
NL12.03.2003
DK12.06.2003
PT12.06.2003
SE12.06.2003
ES30.09.2003
LU14.11.2003
Former [2004/23]AT12.03.2003
BE12.03.2003
FI12.03.2003
GR12.03.2003
NL12.03.2003
DK12.06.2003
PT12.06.2003
SE12.06.2003
ES30.09.2003
Former [2004/10]AT12.03.2003
BE12.03.2003
FI12.03.2003
GR12.03.2003
NL12.03.2003
PT12.06.2003
SE12.06.2003
ES30.09.2003
Former [2004/04]AT12.03.2003
FI12.03.2003
GR12.03.2003
NL12.03.2003
PT12.06.2003
SE12.06.2003
ES30.09.2003
Former [2003/50]AT12.03.2003
FI12.03.2003
GR12.03.2003
NL12.03.2003
PT12.06.2003
SE12.06.2003
Former [2003/47]AT12.03.2003
FI12.03.2003
GR12.03.2003
NL12.03.2003
PT12.06.2003
Former [2003/46]FI12.03.2003
GR12.03.2003
NL12.03.2003
PT12.06.2003
Former [2003/43]FI12.03.2003
NL12.03.2003
PT12.06.2003
Former [2003/41]FI12.03.2003
NL12.03.2003
Cited inInternational search[A]WO9422486  (UNIV JEFFERSON [US], et al) [A] 8,11,17 * page 33; figure 7A *;
 [A]  - WALLENFRIEDMAN M A ET AL, "IGF - 1 R antisense and nonsense oligonucleotide therapy for 9L glioblastoma results in an immune response against an unrelated syngeneic tumor in Fischer 344 rats.", 26TH ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE, WASHINGTON, D.C., USA, NOVEMBER 16-21, 1996. SOCIETY FOR NEUROSCIENCE ABSTRACTS 22 (1-3). 1996. 948. ISSN: 0190-5295, XP002055143 [A] 1-18 * the whole document *
 [A]  - WALLENFRIEDMAN M A ET AL, "Effects of IGF-1R antisense and nonsense oligonucleotide administration on 9L glioblastoma and MAT B3 breast cancer tumor growth in Fischer 344 rats.", 87TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, WASHINGTON, D.C., USA, APRIL 20-24, 1996. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING 37 (0). 1996. 354. ISSN: 0197-016X, XP002055144 [A] 1-18 * the whole document *
 [A]  - BASERGA R, "Controlling IGF-receptor function: a possible strategy for tumor therapy", TRENDS IN BIOTECHNOLOGY, (199605), vol. 14, no. 5, page 150-152, XP004035784 [A] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1016/0167-7799(96)10023-8
 [PX]  - WALLENFRIEDMAN M ET AL, "Peripheral vaccine for breast cancer: Insulin-like growth factor receptor ( IGF - 1R ) antisense oligonucleotide (AON) modified tumor cells protect against peripheral disease and brain metastases.", EIGHTY-EIGHTH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, SAN DIEGO, CALIFORNIA, USA, APRIL 12-16, 1997. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING 38 (0). 1997. 617. ISSN: 0197-016X, XP002055145 [PX] 1-18 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.